The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Polio (Poliomyelitis) Vaccines Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2028
Synopsis
The Polio (Poliomyelitis) Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Polio (Poliomyelitis) Vaccines market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Research & Academic Laboratories accounting for % of the Polio (Poliomyelitis) Vaccines global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Inactivated Polio Vaccine (IPV) segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Polio (Poliomyelitis) Vaccines include Sanofi, GSK, Bibcol, Serum Institute, and Tiantan Biological, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Polio (Poliomyelitis) Vaccines market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Inactivated Polio Vaccine (IPV)
Oral Polio Vaccine (OPV)
Market segment by Application can be divided into
Research & Academic Laboratories
Pharmaceutical & Biotechnology Companies
Others
The key market players for global Polio (Poliomyelitis) Vaccines market are listed below:
Sanofi
GSK
Bibcol
Serum Institute
Tiantan Biological
IMBCA
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Polio (Poliomyelitis) Vaccines product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Polio (Poliomyelitis) Vaccines, with price, sales, revenue and global market share of Polio (Poliomyelitis) Vaccines from 2019 to 2022.
Chapter 3, the Polio (Poliomyelitis) Vaccines competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Polio (Poliomyelitis) Vaccines breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Polio (Poliomyelitis) Vaccines market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Polio (Poliomyelitis) Vaccines.
Chapter 13, 14, and 15, to describe Polio (Poliomyelitis) Vaccines sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Geographical Area
Global
The Polio (Poliomyelitis) Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Polio (Poliomyelitis) Vaccines market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Research & Academic Laboratories accounting for % of the Polio (Poliomyelitis) Vaccines global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Inactivated Polio Vaccine (IPV) segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Polio (Poliomyelitis) Vaccines include Sanofi, GSK, Bibcol, Serum Institute, and Tiantan Biological, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Polio (Poliomyelitis) Vaccines market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Inactivated Polio Vaccine (IPV)
Oral Polio Vaccine (OPV)
Market segment by Application can be divided into
Research & Academic Laboratories
Pharmaceutical & Biotechnology Companies
Others
The key market players for global Polio (Poliomyelitis) Vaccines market are listed below:
Sanofi
GSK
Bibcol
Serum Institute
Tiantan Biological
IMBCA
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Polio (Poliomyelitis) Vaccines product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Polio (Poliomyelitis) Vaccines, with price, sales, revenue and global market share of Polio (Poliomyelitis) Vaccines from 2019 to 2022.
Chapter 3, the Polio (Poliomyelitis) Vaccines competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Polio (Poliomyelitis) Vaccines breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Polio (Poliomyelitis) Vaccines market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Polio (Poliomyelitis) Vaccines.
Chapter 13, 14, and 15, to describe Polio (Poliomyelitis) Vaccines sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Geographical Area
Global
Index1 Market Overview
1.1 Polio (Poliomyelitis) Vaccines Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Polio (Poliomyelitis) Vaccines Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Inactivated Polio Vaccine (IPV)
1.2.3 Oral Polio Vaccine (OPV)
1.3 Market Analysis by Application
1.3.1 Overview: Global Polio (Poliomyelitis) Vaccines Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Research & Academic Laboratories
1.3.3 Pharmaceutical & Biotechnology Companies
1.3.4 Others
1.4 Global Polio (Poliomyelitis) Vaccines Market Size & Forecast
1.4.1 Global Polio (Poliomyelitis) Vaccines Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Polio (Poliomyelitis) Vaccines Sales in Volume (2017-2028)
1.4.3 Global Polio (Poliomyelitis) Vaccines Price (2017-2028)
1.5 Global Polio (Poliomyelitis) Vaccines Production Capacity Analysis
1.5.1 Global Polio (Poliomyelitis) Vaccines Total Production Capacity (2017-2028)
1.5.2 Global Polio (Poliomyelitis) Vaccines Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Polio (Poliomyelitis) Vaccines Market Drivers
1.6.2 Polio (Poliomyelitis) Vaccines Market Restraints
1.6.3 Polio (Poliomyelitis) Vaccines Trends Analysis
2 Manufacturers Profiles
2.1 Sanofi
2.1.1 Sanofi Details
2.1.2 Sanofi Major Business
2.1.3 Sanofi Polio (Poliomyelitis) Vaccines Product and Services
2.1.4 Sanofi Polio (Poliomyelitis) Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 GSK
2.2.1 GSK Details
2.2.2 GSK Major Business
2.2.3 GSK Polio (Poliomyelitis) Vaccines Product and Services
2.2.4 GSK Polio (Poliomyelitis) Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Bibcol
2.3.1 Bibcol Details
2.3.2 Bibcol Major Business
2.3.3 Bibcol Polio (Poliomyelitis) Vaccines Product and Services
2.3.4 Bibcol Polio (Poliomyelitis) Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Serum Institute
2.4.1 Serum Institute Details
2.4.2 Serum Institute Major Business
2.4.3 Serum Institute Polio (Poliomyelitis) Vaccines Product and Services
2.4.4 Serum Institute Polio (Poliomyelitis) Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Tiantan Biological
2.5.1 Tiantan Biological Details
2.5.2 Tiantan Biological Major Business
2.5.3 Tiantan Biological Polio (Poliomyelitis) Vaccines Product and Services
2.5.4 Tiantan Biological Polio (Poliomyelitis) Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 IMBCA
2.6.1 IMBCA Details
2.6.2 IMBCA Major Business
2.6.3 IMBCA Polio (Poliomyelitis) Vaccines Product and Services
2.6.4 IMBCA Polio (Poliomyelitis) Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Panacea Biotec Ltd
2.7.1 Panacea Biotec Ltd Details
2.7.2 Panacea Biotec Ltd Major Business
2.7.3 Panacea Biotec Ltd Polio (Poliomyelitis) Vaccines Product and Services
2.7.4 Panacea Biotec Ltd Polio (Poliomyelitis) Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Bio-Med
2.8.1 Bio-Med Details
2.8.2 Bio-Med Major Business
2.8.3 Bio-Med Polio (Poliomyelitis) Vaccines Product and Services
2.8.4 Bio-Med Polio (Poliomyelitis) Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Halfkin Bio-Pharmaceuticals
2.9.1 Halfkin Bio-Pharmaceuticals Details
2.9.2 Halfkin Bio-Pharmaceuticals Major Business
2.9.3 Halfkin Bio-Pharmaceuticals Polio (Poliomyelitis) Vaccines Product and Services
2.9.4 Halfkin Bio-Pharmaceuticals Polio (Poliomyelitis) Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Polio (Poliomyelitis) Vaccines Breakdown Data by Manufacturer
3.1 Global Polio (Poliomyelitis) Vaccines Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Polio (Poliomyelitis) Vaccines Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Polio (Poliomyelitis) Vaccines
3.4 Market Concentration Rate
3.4.1 Top 3 Polio (Poliomyelitis) Vaccines Manufacturer Market Share in 2021
3.4.2 Top 6 Polio (Poliomyelitis) Vaccines Manufacturer Market Share in 2021
3.5 Global Polio (Poliomyelitis) Vaccines Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Polio (Poliomyelitis) Vaccines Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Polio (Poliomyelitis) Vaccines Market Size by Region
4.1.1 Global Polio (Poliomyelitis) Vaccines Sales in Volume by Region (2017-2028)
4.1.2 Global Polio (Poliomyelitis) Vaccines Revenue by Region (2017-2028)
4.2 North America Polio (Poliomyelitis) Vaccines Revenue (2017-2028)
4.3 Europe Polio (Poliomyelitis) Vaccines Revenue (2017-2028)
4.4 Asia-Pacific Polio (Poliomyelitis) Vaccines Revenue (2017-2028)
4.5 South America Polio (Poliomyelitis) Vaccines Revenue (2017-2028)
4.6 Middle East and Africa Polio (Poliomyelitis) Vaccines Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Polio (Poliomyelitis) Vaccines Sales in Volume by Type (2017-2028)
5.2 Global Polio (Poliomyelitis) Vaccines Revenue by Type (2017-2028)
5.3 Global Polio (Poliomyelitis) Vaccines Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Polio (Poliomyelitis) Vaccines Sales in Volume by Application (2017-2028)
6.2 Global Polio (Poliomyelitis) Vaccines Revenue by Application (2017-2028)
6.3 Global Polio (Poliomyelitis) Vaccines Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Polio (Poliomyelitis) Vaccines Sales by Type (2017-2028)
7.2 North America Polio (Poliomyelitis) Vaccines Sales by Application (2017-2028)
7.3 North America Polio (Poliomyelitis) Vaccines Market Size by Country
7.3.1 North America Polio (Poliomyelitis) Vaccines Sales in Volume by Country (2017-2028)
7.3.2 North America Polio (Poliomyelitis) Vaccines Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Polio (Poliomyelitis) Vaccines Sales by Type (2017-2028)
8.2 Europe Polio (Poliomyelitis) Vaccines Sales by Application (2017-2028)
8.3 Europe Polio (Poliomyelitis) Vaccines Market Size by Country
8.3.1 Europe Polio (Poliomyelitis) Vaccines Sales in Volume by Country (2017-2028)
8.3.2 Europe Polio (Poliomyelitis) Vaccines Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Polio (Poliomyelitis) Vaccines Sales by Type (2017-2028)
9.2 Asia-Pacific Polio (Poliomyelitis) Vaccines Sales by Application (2017-2028)
9.3 Asia-Pacific Polio (Poliomyelitis) Vaccines Market Size by Region
9.3.1 Asia-Pacific Polio (Poliomyelitis) Vaccines Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Polio (Poliomyelitis) Vaccines Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Polio (Poliomyelitis) Vaccines Sales by Type (2017-2028)
10.2 South America Polio (Poliomyelitis) Vaccines Sales by Application (2017-2028)
10.3 South America Polio (Poliomyelitis) Vaccines Market Size by Country
10.3.1 South America Polio (Poliomyelitis) Vaccines Sales in Volume by Country (2017-2028)
10.3.2 South America Polio (Poliomyelitis) Vaccines Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Polio (Poliomyelitis) Vaccines Sales by Type (2017-2028)
11.2 Middle East & Africa Polio (Poliomyelitis) Vaccines Sales by Application (2017-2028)
11.3 Middle East & Africa Polio (Poliomyelitis) Vaccines Market Size by Country
11.3.1 Middle East & Africa Polio (Poliomyelitis) Vaccines Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Polio (Poliomyelitis) Vaccines Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Polio (Poliomyelitis) Vaccines and Key Manufacturers
12.2 Manufacturing Costs Percentage of Polio (Poliomyelitis) Vaccines
12.3 Polio (Poliomyelitis) Vaccines Production Process
12.4 Polio (Poliomyelitis) Vaccines Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Polio (Poliomyelitis) Vaccines Typical Distributors
13.3 Polio (Poliomyelitis) Vaccines Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of TablesList of Tables
Table 1. Global Polio (Poliomyelitis) Vaccines Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Polio (Poliomyelitis) Vaccines Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Sanofi Basic Information, Manufacturing Base and Competitors
Table 4. Sanofi Major Business
Table 5. Sanofi Polio (Poliomyelitis) Vaccines Product and Services
Table 6. Sanofi Polio (Poliomyelitis) Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. GSK Basic Information, Manufacturing Base and Competitors
Table 8. GSK Major Business
Table 9. GSK Polio (Poliomyelitis) Vaccines Product and Services
Table 10. GSK Polio (Poliomyelitis) Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Bibcol Basic Information, Manufacturing Base and Competitors
Table 12. Bibcol Major Business
Table 13. Bibcol Polio (Poliomyelitis) Vaccines Product and Services
Table 14. Bibcol Polio (Poliomyelitis) Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Serum Institute Basic Information, Manufacturing Base and Competitors
Table 16. Serum Institute Major Business
Table 17. Serum Institute Polio (Poliomyelitis) Vaccines Product and Services
Table 18. Serum Institute Polio (Poliomyelitis) Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Tiantan Biological Basic Information, Manufacturing Base and Competitors
Table 20. Tiantan Biological Major Business
Table 21. Tiantan Biological Polio (Poliomyelitis) Vaccines Product and Services
Table 22. Tiantan Biological Polio (Poliomyelitis) Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. IMBCA Basic Information, Manufacturing Base and Competitors
Table 24. IMBCA Major Business
Table 25. IMBCA Polio (Poliomyelitis) Vaccines Product and Services
Table 26. IMBCA Polio (Poliomyelitis) Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Panacea Biotec Ltd Basic Information, Manufacturing Base and Competitors
Table 28. Panacea Biotec Ltd Major Business
Table 29. Panacea Biotec Ltd Polio (Poliomyelitis) Vaccines Product and Services
Table 30. Panacea Biotec Ltd Polio (Poliomyelitis) Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Bio-Med Basic Information, Manufacturing Base and Competitors
Table 32. Bio-Med Major Business
Table 33. Bio-Med Polio (Poliomyelitis) Vaccines Product and Services
Table 34. Bio-Med Polio (Poliomyelitis) Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Halfkin Bio-Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 36. Halfkin Bio-Pharmaceuticals Major Business
Table 37. Halfkin Bio-Pharmaceuticals Polio (Poliomyelitis) Vaccines Product and Services
Table 38. Halfkin Bio-Pharmaceuticals Polio (Poliomyelitis) Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Global Polio (Poliomyelitis) Vaccines Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 40. Global Polio (Poliomyelitis) Vaccines Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 41. Market Position of Manufacturers in Polio (Poliomyelitis) Vaccines, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 42. Global Polio (Poliomyelitis) Vaccines Production Capacity by Company, (K Units): 2020 VS 2021
Table 43. Head Office and Polio (Poliomyelitis) Vaccines Production Site of Key Manufacturer
Table 44. Polio (Poliomyelitis) Vaccines New Entrant and Capacity Expansion Plans
Table 45. Polio (Poliomyelitis) Vaccines Mergers & Acquisitions in the Past Five Years
Table 46. Global Polio (Poliomyelitis) Vaccines Sales by Region (2017-2022) & (K Units)
Table 47. Global Polio (Poliomyelitis) Vaccines Sales by Region (2023-2028) & (K Units)
Table 48. Global Polio (Poliomyelitis) Vaccines Revenue by Region (2017-2022) & (USD Million)
Table 49. Global Polio (Poliomyelitis) Vaccines Revenue by Region (2023-2028) & (USD Million)
Table 50. Global Polio (Poliomyelitis) Vaccines Sales by Type (2017-2022) & (K Units)
Table 51. Global Polio (Poliomyelitis) Vaccines Sales by Type (2023-2028) & (K Units)
Table 52. Global Polio (Poliomyelitis) Vaccines Revenue by Type (2017-2022) & (USD Million)
Table 53. Global Polio (Poliomyelitis) Vaccines Revenue by Type (2023-2028) & (USD Million)
Table 54. Global Polio (Poliomyelitis) Vaccines Price by Type (2017-2022) & (USD/Unit)
Table 55. Global Polio (Poliomyelitis) Vaccines Price by Type (2023-2028) & (USD/Unit)
Table 56. Global Polio (Poliomyelitis) Vaccines Sales by Application (2017-2022) & (K Units)
Table 57. Global Polio (Poliomyelitis) Vaccines Sales by Application (2023-2028) & (K Units)
Table 58. Global Polio (Poliomyelitis) Vaccines Revenue by Application (2017-2022) & (USD Million)
Table 59. Global Polio (Poliomyelitis) Vaccines Revenue by Application (2023-2028) & (USD Million)
Table 60. Global Polio (Poliomyelitis) Vaccines Price by Application (2017-2022) & (USD/Unit)
Table 61. Global Polio (Poliomyelitis) Vaccines Price by Application (2023-2028) & (USD/Unit)
Table 62. North America Polio (Poliomyelitis) Vaccines Sales by Country (2017-2022) & (K Units)
Table 63. North America Polio (Poliomyelitis) Vaccines Sales by Country (2023-2028) & (K Units)
Table 64. North America Polio (Poliomyelitis) Vaccines Revenue by Country (2017-2022) & (USD Million)
Table 65. North America Polio (Poliomyelitis) Vaccines Revenue by Country (2023-2028) & (USD Million)
Table 66. North America Polio (Poliomyelitis) Vaccines Sales by Type (2017-2022) & (K Units)
Table 67. North America Polio (Poliomyelitis) Vaccines Sales by Type (2023-2028) & (K Units)
Table 68. North America Polio (Poliomyelitis) Vaccines Sales by Application (2017-2022) & (K Units)
Table 69. North America Polio (Poliomyelitis) Vaccines Sales by Application (2023-2028) & (K Units)
Table 70. Europe Polio (Poliomyelitis) Vaccines Sales by Country (2017-2022) & (K Units)
Table 71. Europe Polio (Poliomyelitis) Vaccines Sales by Country (2023-2028) & (K Units)
Table 72. Europe Polio (Poliomyelitis) Vaccines Revenue by Country (2017-2022) & (USD Million)
Table 73. Europe Polio (Poliomyelitis) Vaccines Revenue by Country (2023-2028) & (USD Million)
Table 74. Europe Polio (Poliomyelitis) Vaccines Sales by Type (2017-2022) & (K Units)
Table 75. Europe Polio (Poliomyelitis) Vaccines Sales by Type (2023-2028) & (K Units)
Table 76. Europe Polio (Poliomyelitis) Vaccines Sales by Application (2017-2022) & (K Units)
Table 77. Europe Polio (Poliomyelitis) Vaccines Sales by Application (2023-2028) & (K Units)
Table 78. Asia-Pacific Polio (Poliomyelitis) Vaccines Sales by Region (2017-2022) & (K Units)
Table 79. Asia-Pacific Polio (Poliomyelitis) Vaccines Sales by Region (2023-2028) & (K Units)
Table 80. Asia-Pacific Polio (Poliomyelitis) Vaccines Revenue by Region (2017-2022) & (USD Million)
Table 81. Asia-Pacific Polio (Poliomyelitis) Vaccines Revenue by Region (2023-2028) & (USD Million)
Table 82. Asia-Pacific Polio (Poliomyelitis) Vaccines Sales by Type (2017-2022) & (K Units)
Table 83. Asia-Pacific Polio (Poliomyelitis) Vaccines Sales by Type (2023-2028) & (K Units)
Table 84. Asia-Pacific Polio (Poliomyelitis) Vaccines Sales by Application (2017-2022) & (K Units)
Table 85. Asia-Pacific Polio (Poliomyelitis) Vaccines Sales by Application (2023-2028) & (K Units)
Table 86. South America Polio (Poliomyelitis) Vaccines Sales by Country (2017-2022) & (K Units)
Table 87. South America Polio (Poliomyelitis) Vaccines Sales by Country (2023-2028) & (K Units)
Table 88. South America Polio (Poliomyelitis) Vaccines Revenue by Country (2017-2022) & (USD Million)
Table 89. South America Polio (Poliomyelitis) Vaccines Revenue by Country (2023-2028) & (USD Million)
Table 90. South America Polio (Poliomyelitis) Vaccines Sales by Type (2017-2022) & (K Units)
Table 91. South America Polio (Poliomyelitis) Vaccines Sales by Type (2023-2028) & (K Units)
Table 92. South America Polio (Poliomyelitis) Vaccines Sales by Application (2017-2022) & (K Units)
Table 93. South America Polio (Poliomyelitis) Vaccines Sales by Application (2023-2028) & (K Units)
Table 94. Middle East & Africa Polio (Poliomyelitis) Vaccines Sales by Region (2017-2022) & (K Units)
Table 95. Middle East & Africa Polio (Poliomyelitis) Vaccines Sales by Region (2023-2028) & (K Units)
Table 96. Middle East & Africa Polio (Poliomyelitis) Vaccines Revenue by Region (2017-2022) & (USD Million)
Table 97. Middle East & Africa Polio (Poliomyelitis) Vaccines Revenue by Region (2023-2028) & (USD Million)
Table 98. Middle East & Africa Polio (Poliomyelitis) Vaccines Sales by Type (2017-2022) & (K Units)
Table 99. Middle East & Africa Polio (Poliomyelitis) Vaccines Sales by Type (2023-2028) & (K Units)
Table 100. Middle East & Africa Polio (Poliomyelitis) Vaccines Sales by Application (2017-2022) & (K Units)
Table 101. Middle East & Africa Polio (Poliomyelitis) Vaccines Sales by Application (2023-2028) & (K Units)
Table 102. Polio (Poliomyelitis) Vaccines Raw Material
Table 103. Key Manufacturers of Polio (Poliomyelitis) Vaccines Raw Materials
Table 104. Direct Channel Pros & Cons
Table 105. Indirect Channel Pros & Cons
Table 106. Polio (Poliomyelitis) Vaccines Typical Distributors
Table 107. Polio (Poliomyelitis) Vaccines Typical Customers
List of Figures
Figure 1. Polio (Poliomyelitis) Vaccines Picture
Figure 2. Global Polio (Poliomyelitis) Vaccines Revenue Market Share by Type in 2021
Figure 3. Inactivated Polio Vaccine (IPV)
Figure 4. Oral Polio Vaccine (OPV)
Figure 5. Global Polio (Poliomyelitis) Vaccines Revenue Market Share by Application in 2021
Figure 6. Research & Academic Laboratories
Figure 7. Pharmaceutical & Biotechnology Companies
Figure 8. Others
Figure 9. Global Polio (Poliomyelitis) Vaccines Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 10. Global Polio (Poliomyelitis) Vaccines Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Polio (Poliomyelitis) Vaccines Sales (2017-2028) & (K Units)
Figure 12. Global Polio (Poliomyelitis) Vaccines Price (2017-2028) & (USD/Unit)
Figure 13. Global Polio (Poliomyelitis) Vaccines Production Capacity (2017-2028) & (K Units)
Figure 14. Global Polio (Poliomyelitis) Vaccines Production Capacity by Geographic Region: 2022 VS 2028
Figure 15. Polio (Poliomyelitis) Vaccines Market Drivers
Figure 16. Polio (Poliomyelitis) Vaccines Market Restraints
Figure 17. Polio (Poliomyelitis) Vaccines Market Trends
Figure 18. Global Polio (Poliomyelitis) Vaccines Sales Market Share by Manufacturer in 2021
Figure 19. Global Polio (Poliomyelitis) Vaccines Revenue Market Share by Manufacturer in 2021
Figure 20. Polio (Poliomyelitis) Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 21. Top 3 Polio (Poliomyelitis) Vaccines Manufacturer (Revenue) Market Share in 2021
Figure 22. Top 6 Polio (Poliomyelitis) Vaccines Manufacturer (Revenue) Market Share in 2021
Figure 23. Global Polio (Poliomyelitis) Vaccines Sales Market Share by Region (2017-2028)
Figure 24. Global Polio (Poliomyelitis) Vaccines Revenue Market Share by Region (2017-2028)
Figure 25. North America Polio (Poliomyelitis) Vaccines Revenue (2017-2028) & (USD Million)
Figure 26. Europe Polio (Poliomyelitis) Vaccines Revenue (2017-2028) & (USD Million)
Figure 27. Asia-Pacific Polio (Poliomyelitis) Vaccines Revenue (2017-2028) & (USD Million)
Figure 28. South America Polio (Poliomyelitis) Vaccines Revenue (2017-2028) & (USD Million)
Figure 29. Middle East & Africa Polio (Poliomyelitis) Vaccines Revenue (2017-2028) & (USD Million)
Figure 30. Global Polio (Poliomyelitis) Vaccines Sales Market Share by Type (2017-2028)
Figure 31. Global Polio (Poliomyelitis) Vaccines Revenue Market Share by Type (2017-2028)
Figure 32. Global Polio (Poliomyelitis) Vaccines Price by Type (2017-2028) & (USD/Unit)
Figure 33. Global Polio (Poliomyelitis) Vaccines Sales Market Share by Application (2017-2028)
Figure 34. Global Polio (Poliomyelitis) Vaccines Revenue Market Share by Application (2017-2028)
Figure 35. Global Polio (Poliomyelitis) Vaccines Price by Application (2017-2028) & (USD/Unit)
Figure 36. North America Polio (Poliomyelitis) Vaccines Sales Market Share by Type (2017-2028)
Figure 37. North America Polio (Poliomyelitis) Vaccines Sales Market Share by Application (2017-2028)
Figure 38. North America Polio (Poliomyelitis) Vaccines Sales Market Share by Country (2017-2028)
Figure 39. North America Polio (Poliomyelitis) Vaccines Revenue Market Share by Country (2017-2028)
Figure 40. United States Polio (Poliomyelitis) Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Canada Polio (Poliomyelitis) Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Mexico Polio (Poliomyelitis) Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Europe Polio (Poliomyelitis) Vaccines Sales Market Share by Type (2017-2028)
Figure 44. Europe Polio (Poliomyelitis) Vaccines Sales Market Share by Application (2017-2028)
Figure 45. Europe Polio (Poliomyelitis) Vaccines Sales Market Share by Country (2017-2028)
Figure 46. Europe Polio (Poliomyelitis) Vaccines Revenue Market Share by Country (2017-2028)
Figure 47. Germany Polio (Poliomyelitis) Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. France Polio (Poliomyelitis) Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. United Kingdom Polio (Poliomyelitis) Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Russia Polio (Poliomyelitis) Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Italy Polio (Poliomyelitis) Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Asia-Pacific Polio (Poliomyelitis) Vaccines Sales Market Share by Region (2017-2028)
Figure 53. Asia-Pacific Polio (Poliomyelitis) Vaccines Sales Market Share by Application (2017-2028)
Figure 54. Asia-Pacific Polio (Poliomyelitis) Vaccines Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Polio (Poliomyelitis) Vaccines Revenue Market Share by Region (2017-2028)
Figure 56. China Polio (Poliomyelitis) Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan Polio (Poliomyelitis) Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Korea Polio (Poliomyelitis) Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India Polio (Poliomyelitis) Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia Polio (Poliomyelitis) Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia Polio (Poliomyelitis) Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America Polio (Poliomyelitis) Vaccines Sales Market Share by Type (2017-2028)
Figure 63. South America Polio (Poliomyelitis) Vaccines Sales Market Share by Application (2017-2028)
Figure 64. South America Polio (Poliomyelitis) Vaccines Sales Market Share by Country (2017-2028)
Figure 65. South America Polio (Poliomyelitis) Vaccines Revenue Market Share by Country (2017-2028)
Figure 66. Brazil Polio (Poliomyelitis) Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Argentina Polio (Poliomyelitis) Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Middle East & Africa Polio (Poliomyelitis) Vaccines Sales Market Share by Type (2017-2028)
Figure 69. Middle East & Africa Polio (Poliomyelitis) Vaccines Sales Market Share by Application (2017-2028)
Figure 70. Middle East & Africa Polio (Poliomyelitis) Vaccines Sales Market Share by Region (2017-2028)
Figure 71. Middle East & Africa Polio (Poliomyelitis) Vaccines Revenue Market Share by Region (2017-2028)
Figure 72. Turkey Polio (Poliomyelitis) Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Egypt Polio (Poliomyelitis) Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia Polio (Poliomyelitis) Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. South Africa Polio (Poliomyelitis) Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Manufacturing Cost Structure Analysis of Polio (Poliomyelitis) Vaccines in 2021
Figure 77. Manufacturing Process Analysis of Polio (Poliomyelitis) Vaccines
Figure 78. Polio (Poliomyelitis) Vaccines Industrial Chain
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source
Published By : GlobalInfoResearch
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
